FR2361114A1 - Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus - Google Patents

Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus

Info

Publication number
FR2361114A1
FR2361114A1 FR7634015A FR7634015A FR2361114A1 FR 2361114 A1 FR2361114 A1 FR 2361114A1 FR 7634015 A FR7634015 A FR 7634015A FR 7634015 A FR7634015 A FR 7634015A FR 2361114 A1 FR2361114 A1 FR 2361114A1
Authority
FR
France
Prior art keywords
cephalosporin
analogues
preparation
new products
antibacterial property
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7634015A
Other languages
English (en)
French (fr)
Other versions
FR2361114B1 (enExample
Inventor
Masayuki Narisada
Hiroshi Onoue
Teruji Tsuji
Yasuhiro Nishitani
Mitsuru Yoshioka
Yoshio Hamashima
Wataru Nagata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4675975A external-priority patent/GB1569254A/en
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of FR2361114A1 publication Critical patent/FR2361114A1/fr
Application granted granted Critical
Publication of FR2361114B1 publication Critical patent/FR2361114B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7634015A 1975-11-12 1976-11-10 Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus Granted FR2361114A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4675975A GB1569254A (en) 1975-11-12 1975-11-12 Preparation of a-(2 -acetonyloxy-4-oxo-azetidin-1-yl) glycolic acids and derivatives thereof and their use in preparing oxacephalosporins
GB4989175 1975-12-04

Publications (2)

Publication Number Publication Date
FR2361114A1 true FR2361114A1 (fr) 1978-03-10
FR2361114B1 FR2361114B1 (enExample) 1982-09-17

Family

ID=26265894

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7634015A Granted FR2361114A1 (fr) 1975-11-12 1976-11-10 Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus

Country Status (7)

Country Link
JP (1) JPS5265292A (enExample)
AU (1) AU502797B2 (enExample)
CA (1) CA1070688A (enExample)
CH (1) CH636617A5 (enExample)
DE (1) DE2651771A1 (enExample)
FR (1) FR2361114A1 (enExample)
NL (1) NL7612638A (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS607635B2 (ja) * 1976-04-27 1985-02-26 塩野義製薬株式会社 オキサゾリジン化合物
CA1076125A (en) * 1976-08-09 1980-04-22 Masayuki Narisada Intermediates for cephalosporin analogues
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
JPS609718B2 (ja) * 1977-08-25 1985-03-12 塩野義製薬株式会社 チアジアゾリルチオセフアロスポリン類縁抗生物質
IT1102408B (it) * 1977-12-23 1985-10-07 Fujisawa Pharmaceutical Co Composti analoghi della cefalosforina e procedimenti per la loro preparazione
DE3225269A1 (de) * 1982-07-06 1984-01-12 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 7-amino-1-dethia-1-oxa-3-hydroxymethyl-cephem-4-carbonsaeuren

Also Published As

Publication number Publication date
CH636617A5 (en) 1983-06-15
JPS5265292A (en) 1977-05-30
AU1959876A (en) 1978-05-18
AU502797B2 (en) 1979-08-09
CA1070688A (en) 1980-01-29
NL7612638A (nl) 1977-05-16
FR2361114B1 (enExample) 1982-09-17
DE2651771A1 (de) 1977-05-26

Similar Documents

Publication Publication Date Title
NO834146L (no) Fremgangsmaate for fremstilling av epimert azahomoerytromycin a
ES468475A1 (es) Procedimiento para la preparacion de derivados de cefem
JPS56142289A (en) Cephalosporin derivative and manufacture
FI864825A7 (fi) Cefalosporinderivat.
ES8407495A1 (es) Procedimiento para preparar sales por adicion de acidos de compuestos de cefem cristalizados
FR2361114A1 (fr) Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
IL57853A (en) Sisomycin derivatives,their production and pharmaceutical compositions and fodder containing them
IL35875A0 (en) New pharmaceutical compositions for the treatment of microbial infections containing a glutamic acid derivative
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
SE7514646L (sv) Cefalosporinderivat och forfarande for framstellning derav.
JPS54154785A (en) Cephem derivative and its manufacture
SE7612963L (sv) Tienamycinderivat
SE7612961L (sv) Tienamycinderivat
ES431688A1 (es) Procedimiento para la preparacion de compuestos derivados de4-oxol-1-piridinil penicilina y cefalosporina.
GB1539053A (en) Process for the preparation of alpha-(2-oxoimidazolidinyl carbonylamino)-acetamido cephalosporins
ATE18560T1 (de) Cephemderivate und verfahren zu ihrer herstellung.
GB1533413A (en) Penicillins
ATE75746T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung.
IE39830L (en) Cephalosporin derivatives
GB1442222A (en) Benzodiazepine derivatives
ES8101601A1 (es) Un procedimiento para la preparacion de una penicilina
FR2282897A1 (fr) Procede de preparation de derives de cephalosporines a activite antibiotique a partir d'aminoacides et nouveaux produits ainsi obtenus
SU1032745A1 (ru) 3-тиосемикарбазон-1,1-дифенилиндандиона, повышающий физическую выносливость

Legal Events

Date Code Title Description
ST Notification of lapse